
Join to view full profile
190 Pembrooke CirSuite 101Phoenixville, PA 19460
Phone+1 610-415-9486
Fax+1 610-415-9486
Dr. Babinchak is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ohio State University HospitalFellowship, Infectious Disease, 1987 - 1989
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 1984 - 1987
Northeast Ohio Medical UniversityClass of 1984
Certifications & Licensure
OH State Medical License 1988 - 2027
PA State Medical License 1985 - 2026
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects Start of enrollment: 2016 May 27
Publications & Presentations
PubMed
- 151 citationsTigecycline: an update.Gary E. Stein, Timothy Babinchak
Diagnostic Microbiology and Infectious Disease. 2013-04-01 - 1 citationsClarification to the Systematic Review and Meta-Analysis Involving TigecyclinePaul C. McGovern, Timothy Babinchak, Alvaro Quintana
Antimicrobial Agents and Chemotherapy. 2011-10-01 - 56 citationsRising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.Stephen Hawser, Samuel K. Bouchillon, Daryl J. Hoban, Michael J. Dowzicky, Tim Babinchak
International Journal of Antimicrobial Agents. 2011-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: